Hip arthropathy
Conditions
Interventions
Group 1:Pericapsular nerve block with 0.375% ropivacaine
Group 2:Pericapsular nerve block with 0.75% ropivacaine
Sponsors
Department of Anesthesiology, Changzhou Second People's Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 50-80 years, male or female, who plan to undergo hip replacement; 2. ASA grade 1-3; 3. BMI 20~30; 4. Patients who are willing to accept the clinical study and sign relevant informed consent forms.
Exclusion criteria
Exclusion criteria: 1. Serious cardiopulmonary disease and infection; 2. Clinical trials of other drugs: within 30 days or within 7 half lives.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain scores (numeric rating scale); | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of opioids;The number of steps taken in two minutes on the third postoperative day; | — |
Countries
China
Contacts
Public ContactYun Huifang
Changzhou Second People's Hospital
Outcome results
None listed